Works matching DE "ONCOLYTIC virotherapy"
Results: 391
Recombinant Strains of Oncolytic Vaccinia Virus for Cancer Immunotherapy.
- Published in:
- Biochemistry (00062979), 2023, v. 88, n. 6, p. 823, doi. 10.1134/S000629792306010X
- By:
- Publication type:
- Article
Oncolytic Virotherapy and The Immune System.
- Published in:
- International Journal of High School Research, 2023, v. 5, n. 4, p. 28, doi. 10.36838/v5i4.5
- By:
- Publication type:
- Article
An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for Recurrent Breast Cancer.
- Published in:
- Vaccines, 2024, v. 12, n. 9, p. 958, doi. 10.3390/vaccines12090958
- By:
- Publication type:
- Article
The Role of Natural Killer Cells in Oncolytic Virotherapy: Friends or Foes?
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 721, doi. 10.3390/vaccines12070721
- By:
- Publication type:
- Article
Glioblastoma Vaccines as Promising Immune-Therapeutics: Challenges and Current Status.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 655, doi. 10.3390/vaccines12060655
- By:
- Publication type:
- Article
Design Strategies and Precautions for Using Vaccinia Virus in Tumor Virotherapy.
- Published in:
- Vaccines, 2022, v. 10, n. 9, p. 1552, doi. 10.3390/vaccines10091552
- By:
- Publication type:
- Article
In Vivo Oncolytic Virotherapy in Murine Models of Hepatocellular Carcinoma: A Systematic Review.
- Published in:
- Vaccines, 2022, v. 10, n. 9, p. 1541, doi. 10.3390/vaccines10091541
- By:
- Publication type:
- Article
Resistance Mechanisms Influencing Oncolytic Virotherapy, a Systematic Analysis.
- Published in:
- Vaccines, 2021, v. 9, n. 10, p. 1166, doi. 10.3390/vaccines9101166
- By:
- Publication type:
- Article
Advances in Glioblastoma Therapy: An Update on Current Approaches.
- Published in:
- Brain Sciences (2076-3425), 2023, v. 13, n. 11, p. 1536, doi. 10.3390/brainsci13111536
- By:
- Publication type:
- Article
Oncolytic Virotherapy for Melanoma Brain Metastases, a Potential New Treatment Paradigm?
- Published in:
- Brain Sciences (2076-3425), 2021, v. 11, n. 10, p. 1260, doi. 10.3390/brainsci11101260
- By:
- Publication type:
- Article
Against the Resilience of High-Grade Gliomas: Gene Therapies (Part II).
- Published in:
- Brain Sciences (2076-3425), 2021, v. 11, n. 8, p. 976, doi. 10.3390/brainsci11080976
- By:
- Publication type:
- Article
Perceptions of Cancer Through the Ages—From Hippocratic Oncology to Precision Cancer Medicine.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 11, p. 1383, doi. 10.3390/biom14111383
- By:
- Publication type:
- Article
YB-1-based oncolytic virotherapy in combination with CD47 blockade enhances phagocytosis of pediatric sarcoma cells.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1304374
- By:
- Publication type:
- Article
Oncolytic virotherapy for metastatic breast cancer -- a case report.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1186888
- By:
- Publication type:
- Article
Recent advances in oncolytic virus therapy for hepatocellular carcinoma.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1172292
- By:
- Publication type:
- Article
Perioperative oncolytic virotherapy to counteract surgery-induced immunosuppression and improve outcomes in pancreatic ductal adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1071751
- By:
- Publication type:
- Article
CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1175535
- By:
- Publication type:
- Article
Oncolytic immunovirotherapy for high-grade gliomas: A novel and an evolving therapeutic option.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1118246
- By:
- Publication type:
- Article
Fatty acid transport protein inhibition sensitizes breast and ovarian cancers to oncolytic virus therapy via lipid modulation of the tumor microenvironment.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1099459
- By:
- Publication type:
- Article
Global trends of Vaccinia oncolytic virus therapy over the past two decades: Bibliometric and visual analysis.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1063548
- By:
- Publication type:
- Article
Prediction and validation of murine MHC class I epitopes of the recombinant virus VSV-GP.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 1, doi. 10.3389/fimmu.2022.1100730
- By:
- Publication type:
- Article
Dendritic cells and natural killer cells: The road to a successful oncolytic virotherapy.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 01, doi. 10.3389/fimmu.2022.950079
- By:
- Publication type:
- Article
Emerging trends and research foci of oncolytic virotherapy for central nervous system tumors: A bibliometric study.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.975695
- By:
- Publication type:
- Article
The gamble between oncolytic virus therapy and IFN.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.971674
- By:
- Publication type:
- Article
Oncolytic Virotherapy: A New Cornerstone for Immuno-Oncology.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2017, v. 8, p. 37
- Publication type:
- Article
Distinguishing the pros and cons of metabolic reprogramming in oncolytic virus immunotherapy.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 10, p. 1654, doi. 10.1002/ijc.34139
- By:
- Publication type:
- Article
Oncolytic virotherapy -- A novel strategy for cancer therapy.
- Published in:
- Egyptian Journal of Medical Human Genetics, 2018, v. 19, n. 3, p. 165, doi. 10.1016/j.ejmhg.2017.10.006
- By:
- Publication type:
- Article
Evaluating soluble Axl as a biomarker for glioblastoma: A pilot study.
- Published in:
- PLoS ONE, 2024, v. 19, n. 7, p. 1, doi. 10.1371/journal.pone.0301739
- By:
- Publication type:
- Article
Fluorescence-guided assessment of bone and soft-tissue sarcomas for predicting the efficacy of telomerase-specific oncolytic adenovirus.
- Published in:
- PLoS ONE, 2024, v. 19, n. 2, p. 1, doi. 10.1371/journal.pone.0298292
- By:
- Publication type:
- Article
Establishment of a Panel of Human Cell Lines to Identify Cellular Receptors Used by Enteroviruses to Infect Cells.
- Published in:
- International Journal of Molecular Sciences, 2025, v. 26, n. 3, p. 923, doi. 10.3390/ijms26030923
- By:
- Publication type:
- Article
Adenovirus-Neutralizing and Infection-Promoting Activities Measured in Serum of Human Brain Cancer Patients Treated with Oncolytic Adenovirus Ad5-∆24.RGD.
- Published in:
- International Journal of Molecular Sciences, 2025, v. 26, n. 2, p. 854, doi. 10.3390/ijms26020854
- By:
- Publication type:
- Article
Microbubble-Protected Oncolytic Virotherapy Targeted by Sonoporation Induces Tumor Necrosis and T-Lymphocyte Infiltration in Humanized Mice Bearing Triple-Negative Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 24, p. 13697, doi. 10.3390/ijms252413697
- By:
- Publication type:
- Article
The Potential of Oncolytic Virotherapy in the Treatment of Head and Neck Cancer: A Comprehensive Review.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 23, p. 12990, doi. 10.3390/ijms252312990
- By:
- Publication type:
- Article
Strategies for Modifying Adenoviral Vectors for Gene Therapy.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 22, p. 12461, doi. 10.3390/ijms252212461
- By:
- Publication type:
- Article
Enhanced Antitumor Efficacy of Oncolytic Vaccinia Virus Therapy Through Keratin-Mediated Delivery in Triple-Negative Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 21, p. 11470, doi. 10.3390/ijms252111470
- By:
- Publication type:
- Article
Adipose-Derived Stem Cells as Carrier of Pro-Apoptotic Oncolytic Myxoma Virus: To Cross the Blood–Brain Barrier and Treat Murine Glioma.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 20, p. 11225, doi. 10.3390/ijms252011225
- By:
- Publication type:
- Article
Oncolytic Viruses as Reliable Adjuvants in CAR-T Cell Therapy for Solid Tumors.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 20, p. 11127, doi. 10.3390/ijms252011127
- By:
- Publication type:
- Article
Recurrent Glioblastoma—Molecular Underpinnings and Evolving Treatment Paradigms.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 12, p. 6733, doi. 10.3390/ijms25126733
- By:
- Publication type:
- Article
A Review of CAR-T Combination Therapies for Treatment of Gynecological Cancers.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 12, p. 6595, doi. 10.3390/ijms25126595
- By:
- Publication type:
- Article
Combination of FOLFOXIRI Drugs with Oncolytic Coxsackie B3 Virus PD-H Synergistically Induces Oncolysis in the Refractory Colorectal Cancer Cell Line Colo320.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 11, p. 5618, doi. 10.3390/ijms25115618
- By:
- Publication type:
- Article
Molecular Circuits of Immune Sensing and Response to Oncolytic Virotherapy.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 9, p. 4691, doi. 10.3390/ijms25094691
- By:
- Publication type:
- Article
Glioblastoma Therapy: Past, Present and Future.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 5, p. 2529, doi. 10.3390/ijms25052529
- By:
- Publication type:
- Article
Combination of Oncolytic Virotherapy with Different Antitumor Approaches against Glioblastoma.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 4, p. 2042, doi. 10.3390/ijms25042042
- By:
- Publication type:
- Article
Oncolytic Virotherapy: A New Paradigm in Cancer Immunotherapy.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 2, p. 1180, doi. 10.3390/ijms25021180
- By:
- Publication type:
- Article
Targeting Innate Immunity in Glioma Therapy.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 2, p. 947, doi. 10.3390/ijms25020947
- By:
- Publication type:
- Article
Virus Engineering and Applications.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 23, p. 16788, doi. 10.3390/ijms242316788
- By:
- Publication type:
- Article
Development of Zika Virus E Variants for Pseudotyping Retroviral Vectors Targeting Glioblastoma Cells.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 19, p. 14487, doi. 10.3390/ijms241914487
- By:
- Publication type:
- Article
Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of Cancer.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 11, p. 9255, doi. 10.3390/ijms24119255
- By:
- Publication type:
- Article
The Dilemma of HSV-1 Oncolytic Virus Delivery: The Method Choice and Hurdles.
- Published in:
- 2023
- By:
- Publication type:
- Literature Review
Natural Killer Cell-Based Immunotherapy against Glioblastoma.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 2111, doi. 10.3390/ijms24032111
- By:
- Publication type:
- Article